SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool automates liver tumor detection and monitoring

2.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

3.

Year in Review: Multiple Myeloma

4.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

5.

Breast Cancer Incidence Rises in Asian American Women


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot